Skip to main content

Posters

Validation of a FVIII Chromogenic Nijmegen Bethesda Assay for the Detection of Inhibitors in the Presence of Emicizumab (ACE-910)

03 Oct 2019

Published in: NHF Bleeding Disorders Conference (National Hemophilia Foundation)